344 related articles for article (PubMed ID: 24709797)
1. DNA methylation and apoptosis resistance in cancer cells.
Hervouet E; Cheray M; Vallette FM; Cartron PF
Cells; 2013 Jul; 2(3):545-73. PubMed ID: 24709797
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and apoptosis.
Gopisetty G; Ramachandran K; Singal R
Mol Immunol; 2006 Apr; 43(11):1729-40. PubMed ID: 16500705
[TBL] [Abstract][Full Text] [Related]
3. Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology.
Pal R; Srivastava N; Chopra R; Gochhait S; Gupta P; Prakash N; Agarwal G; Bamezai RN
Mol Cancer; 2010 Nov; 9():303. PubMed ID: 21092294
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
5. Physician Education: Apoptosis.
Kataoka S; Tsuruo T
Oncologist; 1996; 1(6):399-401. PubMed ID: 10388021
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological mechanisms of death resistance in colorectal carcinoma.
Huang CY; Yu LC
World J Gastroenterol; 2015 Nov; 21(41):11777-92. PubMed ID: 26557002
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic cell signaling in cancer progression and therapy.
Plati J; Bucur O; Khosravi-Far R
Integr Biol (Camb); 2011 Apr; 3(4):279-96. PubMed ID: 21340093
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
[TBL] [Abstract][Full Text] [Related]
11. DNA Methylation Machinery in the Endometrium and Endometrial Cancer.
Caplakova V; Babusikova E; Blahovcova E; Balharek T; Zelieskova M; Hatok J
Anticancer Res; 2016 Sep; 36(9):4407-20. PubMed ID: 27630276
[TBL] [Abstract][Full Text] [Related]
12. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer.
Paliwal A; Vaissière T; Krais A; Cuenin C; Cros MP; Zaridze D; Moukeria A; Boffetta P; Hainaut P; Brennan P; Herceg Z
Cancer Res; 2010 Apr; 70(7):2779-88. PubMed ID: 20332232
[TBL] [Abstract][Full Text] [Related]
15. Untangling the Roles of Anti-Apoptosis in Regulating Programmed Cell Death using Humanized Yeast Cells.
Clapp C; Portt L; Khoury C; Sheibani S; Eid R; Greenwood M; Vali H; Mandato CA; Greenwood MT
Front Oncol; 2012; 2():59. PubMed ID: 22708116
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
17. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
Yang J; Li G; Zhang K
Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
[TBL] [Abstract][Full Text] [Related]
18. E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway.
Woo SM; Kwon TK
BMB Rep; 2019 Feb; 52(2):119-126. PubMed ID: 30638181
[TBL] [Abstract][Full Text] [Related]
19. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis: programmed cell death at a molecular level.
Schultz DR; Harrington WJ
Semin Arthritis Rheum; 2003 Jun; 32(6):345-69. PubMed ID: 12833244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
